全文获取类型
收费全文 | 179篇 |
免费 | 7篇 |
专业分类
儿科学 | 14篇 |
妇产科学 | 2篇 |
基础医学 | 53篇 |
口腔科学 | 8篇 |
临床医学 | 7篇 |
内科学 | 12篇 |
皮肤病学 | 3篇 |
神经病学 | 28篇 |
特种医学 | 7篇 |
外科学 | 16篇 |
预防医学 | 19篇 |
药学 | 5篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 4篇 |
2017年 | 6篇 |
2016年 | 1篇 |
2015年 | 5篇 |
2014年 | 1篇 |
2013年 | 5篇 |
2012年 | 6篇 |
2011年 | 9篇 |
2010年 | 6篇 |
2009年 | 4篇 |
2008年 | 6篇 |
2007年 | 11篇 |
2006年 | 10篇 |
2005年 | 5篇 |
2004年 | 6篇 |
2003年 | 7篇 |
2002年 | 7篇 |
2001年 | 2篇 |
2000年 | 4篇 |
1999年 | 8篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 3篇 |
1992年 | 11篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 8篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 6篇 |
1983年 | 1篇 |
1979年 | 2篇 |
1972年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有186条查询结果,搜索用时 15 毫秒
51.
Massimo Moretti Maria Giuseppa Grollino Sofia Pavanello Roberta Bonfiglioli Milena Villarini Massimo Appolloni Mariella Carrieri Laura Sabatini Luca Dominici Laura Stronati Giuseppe Mastrangelo Anna Barbieri Cristina Fatigoni Giovanni Battista Bartolucci Elisabetta Ceretti Francesca Mussi Silvano Monarca 《International archives of occupational and environmental health》2015,88(6):683-695
52.
Tapson VF Decousus H Pini M Chong BH Froehlich JB Monreal M Spyropoulos AC Merli GJ Zotz RB Bergmann JF Pavanello R Turpie AG Nakamura M Piovella F Kakkar AK Spencer FA Fitzgerald G Anderson FA;IMPROVE Investigators 《Chest》2007,132(3):936-945
BACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized medical patients who are at risk of venous thromboembolism (VTE) should receive prophylaxis. Our aim was to characterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patients enrolled in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). METHODS: IMPROVE is an ongoing, multinational, observational study. Participating hospitals enroll the first 10 consecutive eligible acutely ill medical patients each month. Patient management is determined by the treating physicians. An analysis of data on VTE prophylaxis practices is presented. RESULTS: From July 2002 to September 30, 2006, 15,156 patients were enrolled from 52 hospitals in 12 countries, of whom 50% received in-hospital pharmacologic and/or mechanical VTE prophylaxis. In the United States and other participating countries, 52% and 43% of patients, respectively, should have received prophylaxis according to guideline recommendations from the American College of Chest Physicians (ACCP). Only approximately 60% of patients who either met the ACCP criteria for requiring prophylaxis or were eligible for enrollment in randomized clinical trials that have shown the benefits of pharmacologic prophylaxis actually received prophylaxis. Practices varied considerably. Intermittent pneumatic compression was the most common form of medical prophylaxis utilized in the United States, although it was used very rarely in other countries (22% vs 0.2%, respectively). Unfractionated heparin was the most frequent pharmacologic approach used in the United States (21% of patients), with low-molecular-weight heparin used most frequently in other participating countries (40%). There was also variable use of elastic stockings in the United States and other participating countries (3% vs 7%, respectively). CONCLUSIONS: Our data suggest that physicians' practices for providing VTE prophylaxis to acutely ill hospitalized medical patients are suboptimal and highlight the need for improved implementation of existing evidence-based guidelines in hospitals. 相似文献
53.
54.
55.
56.
Castagnola E Garrè ML Bertoluzzo L Pignatelli S Pavanello M Caviglia I Caruso S Bagnasco F Moroni C Tacchella A Haupt R 《Journal of pediatric hematology/oncology》2011,33(7):e310-e315
Data regarding the epidemiology febrile neutropenia during chemotherapy for pediatric central nervous system neoplasia are scarce. Data retrieved from a prospective study performed from January 2002 to December 2004 at G.Gaslini Children Hospital, Genoa, Italy, where analyzed to evaluate proportions, rate for 1000 neutropenic days and etiology of fever in neutropenic children receiving gentle, standard, or peripheral blood stem cell transplant (PBSCT) therapy for central nervous system tumor. During the study duration, 243 periods of neutropenia (granulocyte count <1000/cmm), accounting for 3544 patient-days at risk, were documented in 62 children. A total of 72 febrile episodes were observed in 66 (27%) neutropenic periods, for a rate of 20.31. A primary febrile episode was observed in 10% of neutropenic periods after gentle chemotherapy, in 30% after standard chemotherapy, and in 48% after PBSCT (P<0.0001). The rate of primary febrile episodes was 6.19 after a gentle chemotherapy, 27.02 after standard treatment, and 31.02 after PBSCT (P<0.0001). In a multivariable regression model, the type of chemotherapy (gentle vs. standard and PBSCT) and the thresholds of granulocyte count at neutropenia onset (999-501/cmm and 500-101/cmm vs. ≤100/cmm) were the only factors significantly associated with the development of febrile neutropenia. 相似文献
57.
Neither eosinophilic cystitis nor nephrogenic adenoma is often diagnosed in children, with few pediatric cases being reported in the literature. Although these maladies share the same predisposing conditions, namely, chronic irritation or injury to the urothelium and lower urinary tract and symptoms such as dysuria, hematuria, and urinary frequency, their concomitance is exceptional. Herein, we report the case of an 8-year-old boy with a previous history of bladder surgery presenting histologically diagnosed eosinophilic cystitis and nephrogenic adenoma. 相似文献
58.
Hervé Decousus Victor F. Tapson Jean-François Bergmann Beng H. Chong James B. Froehlich Ajay K. Kakkar Geno J. Merli Manuel Monreal Mashio Nakamura Ricardo Pavanello Mario Pini Franco Piovella Frederick A. Spencer Alex C. Spyropoulos Alexander G.G. Turpie Rainer B. Zotz Gordon FitzGerald Frederick A. Anderson 《Chest》2011,139(1):69-79
59.
Assessing Pathogenicity for Novel Mutation/Sequence Variants: The Value of Healthy Older Individuals
Mayana Zatz Rita de Cassia M. Pavanello Naila Cristina V. Louren?o Antonia Cerqueira Monize Lazar Mariz Vainzof 《Neuromolecular medicine》2012,14(4):281-284
Improvement in DNA technology is increasingly revealing unexpected/unknown mutations in healthy persons and generating anxiety due to their still unknown health consequences. We report a 44-year-old healthy father of a 10-year-old daughter with bilateral coloboma and hearing loss, but without muscle weakness, in whom a whole-genome CGH revealed a deletion of exons 38?C44 in the dystrophin gene. This mutation was inherited from her asymptomatic father, who was further clinically and molecularly evaluated for prognosis and genetic counseling (GC). This deletion was never identified by us in 982 Duchenne/Becker patients. To assess whether the present case represents a rare case of non-penetrance, and aiming to obtain more information for prognosis and GC, we suggested that healthy older relatives submit their DNA for analysis, to which several complied. Mutation analysis revealed that his mother, brother, and 56-year-old maternal uncle also carry the 38?C44 deletion, suggesting it an unlikely cause of muscle weakness. Genome sequencing will disclose mutations and variants whose health impact are still unknown, raising important problems in interpreting results, defining prognosis, and discussing GC. We suggest that, in addition to family history, keeping the DNA of older relatives could be very informative, in particular for those interested in having their genome sequenced. 相似文献
60.
Tonini MM Passos-Bueno MR Cerqueira A Matioli SR Pavanello R Zatz M 《Neuromuscular disorders : NMD》2004,14(1):33-38
Facioscapulohumeral muscular dystrophy is an autosomal dominant muscle disorder, mapped to 4q35. It is characterized by remarkable inter- and intrafamilial clinical variability ranging from severe phenotype to asymptomatic carriers. The aim of the present study was to assess the size of the Eco RI fragment in a large sample of asymptomatic or minimally affected carriers as well as symptomatic patients, comparing both sexes, in order to verify if asymptomatic carriers are randomly distributed or concentrated in some particular families and if there is preferential parental transmission (maternal or paternal) resulting in non-penetrant carriers. We have analysed a total of 506 individuals from 106 unrelated families with at least one affected facioscapulohumeral muscular dystrophy proband. In all patients the molecular diagnosis was confirmed following double digestion (Eco RI/Bln I fragment <35 kb). About 20% among probands' relatives who were found to carry the small fragment were asymptomatic or minimally affected, without preferential parental transmission, but with a significantly higher proportion of females (n=37) than males (n=14). Although asymptomatic carriers were found in about 30% of the families, some genealogies seem to concentrate more non-penetrant cases. A significant correlation between the size of the Eco RI fragment and severity of the phenotype was observed in the total sample but surprisingly this correlation is significant only among affected females. The gender difference in clinical manifestation as well as the observation that asymptomatic carriers are not rare should be taken into consideration in genetic counseling of affected patients or 'at-risk' relatives. 相似文献